Latest filing published 02 Oct 2026 for C4 Therapeutics, Inc., €10k. Read the official filing
This profile gathers the share dealings of Kenneth Carl Anderson in C4 Therapeutics, Inc., where the filings describe the role as board member. In total, 26 filings cover trades dated from 2 July 2021 to 1 October 2026.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
The record was last updated on 2 October 2026 with a share grant (€10k) in C4 Therapeutics, Inc. Typically, a trade is published a median of 1 day after it takes place. For comparison, the SEC allows two business days to file a Form 4. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
25 of 26 declarations